Driving reinvestment in R&D for antibiotics and advocating their responsible use


An overview of all DRIVE-AB project partners and participants, including photos and biographies, can be accessed here: DRIVE-AB Participant List.

Click here for details of EFPIA partners

Click here for a list of current Associate Partners


DRIVE-AB Partners in the Spotlight

Enrico Baraldi

Professor at Uppsala University Department of Engineering Sciences

Yehuda Carmeli

Professor at Tel Aviv University Sackler School of Medicine, head of Israeli National Center for Antibiotic Resistance
Co-authored article in the Wall Street Journal

Francesco Ciabuschi

Professor of International Business at Uppsala university (Sweden) Department of Business Studies
– Adjunct Professor at Bologna University (Italy) School of Economics, Management and Statistics

Inge Gyssens

Infectious Disease Specialist at Hasselt University and leader of research projects at Radboud University Medical Center
Slide Set: Consumption of antibiotics in hospitals. Antimicrobial stewardship.

Stephan Harbarth

Professor and consultant at Geneva University Hospitals
– Member of the Faculty of 1000
– Co-authored a Call for Action on the application of international health regulations to the global threat of antimicrobial resistance (published in PLOS Medicine)

Ramanan Laxminarayan

Director of the the Center for Disease Dynamics, Economics and Policy
TED Talk: The coming crisis in antibiotics
Interview with Frontline, PBS

Kevin Outterson

Professor and Co-Director of Health Law at Boston University
– Interview with Boston University

Laura Piddock

Professor of Microbiology and Deputy Director of the Institute of Microbiology and Infection at the University of Birmingham
– Public speaker on antimicrobial resistance
– Founder of the Antimicrobials Research Group

Céline Pulcini

Professor of Infectious Diseases at Nancy University Hospital
Member of the Public Health Research Unit of the University of Lorraine
– Secretary of the ESCMID Study Group for Antibiotic Policies (ESGAP) Executive Committee

John Rex (no longer a partner as of 2017)

Senior Vice President and Head of Infection, Global Medicines Development at AstraZeneca Pharmaceuticals
Video: Challenges to antibiotic discovery
Interview with Frontline, PBS

Ursula Theuretzbacher

Center for Anti-Infective Agents
Independent infectious disease scientist, specialist for anti-infective R&D and clinical practice strategies, science communicator

Christine Årdal

Leader of Access to Medicines/Vaccines group at the Norwegian Institute of Public Health
Meeting at the U.S. Capital Visitor Center, Washington DC
– Member of the Global Health Policy Institute